Comparative Effectiveness of Different Bariatric Procedures in Super Morbid Obesity

Bettencourt‐Silva, Rita; Neves, João Sérgio; Pedro, Jorge; Guerreiro, Vanessa; Ferreira, Maria João; Salazar, Daniela; Souteiro, Pedro; Magalhães, Diogo; Oliveira, Sofia Castro; Queirós, Joana; Belo, Sandra; Varela, Ana; Freitas, Paula; Carvalho, Davide

doi:10.1007/s11695-018-3519-y

Cited by 35 publications

(32 citation statements)

References 38 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The cutoff point of 50 kg/m 2 was set due to the fact that this group of patients is more likely to develop complex obesity-related comorbidities and poses a greater challenge for potential bariatric treatment. Separate analysis of those patients seems to be advisable considering major differences in clinical management of this group [ 13 , 14 ].…”

Section: Methodsmentioning

confidence: 99%

Differences in Compositions of Oral and Fecal Microbiota between Patients with Obesity and Controls

et al. 2021

View full text Add to dashboard Cite

Background and Objectives: The aim of this study was to compare the differences in compositions of oral and fecal bacterial microbiota between patients with morbid obesity and normal-weight controls. Material and Methods: This was a prospective cohort study. The study included group 1 (patients with BMI ≥ 40 kg/m2) and group 2 (patients with BMI from 18.5 to 24.9 kg/m2). Our endpoint was the analysis of the differences in compositions of oral and fecal microbiota between the groups. Oral swabs and fecal samples were collected from the patients. The analysis of microbiota was conducted using next-generation sequencing. Results: Overall, the study included 96 patients; 52 (54.2%) were included in group 1, 44 (39.8%)—in group 2. In group 1, oral microbiota included significantly more bacteria from genera Veillonella, Oribacterium and Soonwooa, whereas, in group 2, Streptobacillus, Parvimonas and Rothia were more common. Fecal microbiota in group 1 included more Bacteroides, Odoribacter and Blautia and group 2 was more abundant in Ruminococcus, Christensenella and Faecalibacterium. Conclusions: Both oral and fecal gastrointestinal microbiota differs significantly among patients with severe obesity and lean individuals.

show abstract

Section: Methodsmentioning

confidence: 99%

Differences in Compositions of Oral and Fecal Microbiota between Patients with Obesity and Controls

et al. 2021

View full text Add to dashboard Cite

show abstract

“…In a study conducted by Silva R et al with 213 SO patients, the group that received SG had EWL% of 58.74 and 59.90 in years 1 and 2, respectively. In the RYGB group, these were 67.58 and 72.19, respectively (29). In a study performed by (27).…”

Section: Discussionmentioning

confidence: 93%

“…Singla V et al conducted a study with 75 SO patients and found that the remission rate for Type 2 DM was 85.7% in the SG group and 77.7% in the RYGB group (p=0.59) (34). Silva et al found that there were no differences in terms of the remission of diabetes in years 1 and 2 among RYGB, SG and AGB (p=0.91-p=0.13) (29). Different pathophysiological mechanisms other than weight loss also play a role in the correction of comorbidities following LSG.…”

Section: Discussionmentioning

confidence: 99%

What is The Effect of Sleeve Gastrectomy in Patients with a BMI ≥ 50 kg/m2?

Ozturk

Çelik

2021

Preprint

View full text Add to dashboard Cite

Background: To investigate the effect of Sleeve Gastrectomy (SG) in patient with a Body Mass Index (BMI)≥50 kg/m² groups on weight loss and comorbidities as the first and alone option. Methods: The prospectively maintained data obtained from patients with a BMI ≥ 50 who underwent SG between February, 2016 - February, 2020 were evaluated. Results: 138 patient with a BMI≥50 kg/m² underwent surgery. Average BMI: 56.36±7.661, age 37.41±12.33. Forty eight patients underwent cholecystectomy and/or hiatal hernia repair (HHR), as well. The percentage of excess weight loss (%EWL) values of patients in months 3, 6, 12 and 24 were 36.70%, 54.34%, 67.58%, 72.45%, 74.14% and the percentage of total weight loss (TWL%) values were 20.17%, 29.59%, 36.93%, 39.62%, 40.65%, respectively. The mean BMI values in month 0 and in the 3rd, 6th, 12th, 18th, 24th months were 56.36, 45.10, 39.76, 35.48, 33.96 and 33.42 respectively. The values measured in the month 0 and in the 3rd, 6th, 12th, 18th, 24th months were significantly different for EWL%, TWL% and BMI variables (p<0.001), but EWL% (p = 0.527), TWL% (p = 0.396) and BMI (p=0.657) were not found significantly different between the 18th and 24th months. When EWL% was accepted as ≥50, the success rate was found to be 93.55%(n=93) and 92%(n=50) in months 12 and 24, respectively. Conclusion: SG appears to be an effective and safe treatment method as the first option for weight loss and for treatment of concomitant disorders in patient with a BMI ≥ 50 kg/m² groups. Further long-term studies are needed to confirm these results.

show abstract

“…Sleeve gastrectomy (SG) (Fig. 4) is somehow similar to RYGB, both in terms of EWL%, or percent decrease in body mass index (BMI, %EBL) and resolution of co-morbidities [4][5][6][7][8][9][10][11]. One of the most important co-morbidities in which bariatric surgery has a positive impact is type 2 diabetes mellitus (DM2), because the weight loss represents a key element in correcting the metabolic alterations of the obese subject with DM2 [12].…”

Section: Introductionmentioning

confidence: 99%

Biliopancreatic Diversion (BPD), Long Common Limb Revisional Biliopancreatic Diversion (BPD + LCL–R), Roux-en-Y Gastric Bypass [RYGB] and Sleeve Gastrectomy (SG) mediate differential quantitative changes in body weight and qualitative modifications in body composition: a 5-year study

et al. 2021

View full text Add to dashboard Cite

Aims Bariatric surgeries induce profound weight loss (decrease in body mass index, BMI), through a decrease in fat mass (FM) and to a much lesser degree of fat-free mass (FFM). Some reports indicate that the weight which is lost after gastric bypass (RYGB) and sleeve gastrectomy (SG) is at least partially regained 2 years after surgery. Here we compare changes in BMI and body composition induced by four bariatric procedures in a 5 years follow-up study. Methods We analyzed retrospectively modifications in BMI, FM and FFM obtained through Roux-en-Y gastric bypass (RYGB), sleeve gastrectomy (SG), biliopancreatic diversion (BPD) and a long common limb revisional biliopancreatic diversion (reduction of the gastric pouch and long common limb; BPD + LCL−R). Patients were evaluated at baseline and yearly for 5 years. Of the whole cohort of 565 patients, a subset of 180 patients had all yearly evaluations, while the remaining had incomplete evaluations. Setting University Hospital. Results In a total of 180 patients evaluated yearly for 5 years, decrease in BMI and FM up to 2 years was more rapid with RYGB and SG than BPD and BPD + LCL−R; with RYGB and SG both BMI and FM slightly increased in the years 3–5. At 5 years, the differences were not significant. When analysing the differences between 2 and 5 years, BPD + LCL−R showed a somewhat greater effect on BMI and FM than RYGB, BPD and SG. Superimposable results were obtained when the whole cohort of 565 patients with incomplete evaluation was considered. Conclusions All surgeries were highly effective in reducing BMI and fat mass at around 2 years; with RYGB and SG both BMI and FM slightly increased in the years 3–5, while BPD and BPD + LCL−R showed a slight further decreases in the same time interval.

show abstract

Comparative Effectiveness of Different Bariatric Procedures in Super Morbid Obesity

Cited by 35 publications

References 38 publications

Differences in Compositions of Oral and Fecal Microbiota between Patients with Obesity and Controls

Differences in Compositions of Oral and Fecal Microbiota between Patients with Obesity and Controls

What is The Effect of Sleeve Gastrectomy in Patients with a BMI ≥ 50 kg/m2?

Biliopancreatic Diversion (BPD), Long Common Limb Revisional Biliopancreatic Diversion (BPD + LCL–R), Roux-en-Y Gastric Bypass [RYGB] and Sleeve Gastrectomy (SG) mediate differential quantitative changes in body weight and qualitative modifications in body composition: a 5-year study

Contact Info

Product

Resources

About